APA (7th ed.) Citation

C, Z., JS, F., L, L., H, S., & M, M. (2022). Complete response to dupilumab in a patient with chronic spontaneous urticaria who did not tolerate omalizumab. JAAD case reports, 32, 109. https://doi.org/10.1016/j.jdcr.2022.12.009

Chicago Style (17th ed.) Citation

C, Zhu, Fok JS, Lin L, Su H, and Maurer M. "Complete Response to Dupilumab in a Patient with Chronic Spontaneous Urticaria Who Did Not Tolerate Omalizumab." JAAD Case Reports 32 (2022): 109. https://doi.org/10.1016/j.jdcr.2022.12.009.

MLA (9th ed.) Citation

C, Zhu, et al. "Complete Response to Dupilumab in a Patient with Chronic Spontaneous Urticaria Who Did Not Tolerate Omalizumab." JAAD Case Reports, vol. 32, 2022, p. 109, https://doi.org/10.1016/j.jdcr.2022.12.009.